{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:08:18Z","timestamp":1780405698793,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["PX2021054"],"award-info":[{"award-number":["PX2021054"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016126","name":"Beijing Hospital Authority","doi-asserted-by":"publisher","award":["DFL20191401"],"award-info":[{"award-number":["DFL20191401"]}],"id":[{"id":"10.13039\/100016126","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.clim.2021.108858","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T12:12:02Z","timestamp":1632226322000},"page":"108858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Progesterone-induced blocking factor-mediated Th1\/Th2 balance correlates with fetal arrest in women who underwent in vitro fertilization and embryo transfer"],"prefix":"10.1016","volume":"232","author":[{"given":"Yonglian","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2021.108858_bb0005","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1055\/a-1056-3148","article-title":"Tacrolimus improves the implantation rate in patients with elevated Th1\/2 helper cell ratio and repeated implantation failure (RIF)","volume":"80","author":"Bahrami-Asl","year":"2020","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"10.1016\/j.clim.2021.108858_bb0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.23736\/S0391-1977.17.02649-9","article-title":"Embryo transfer: timing and techniques","volume":"43","author":"Bortoletto","year":"2018","journal-title":"Minerva Endocrinol."},{"key":"10.1016\/j.clim.2021.108858_bb0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fimmu.2020.00349","article-title":"Altered immune response and implantation failure in progesterone-induced blocking factor-deficient mice","volume":"11","author":"Csabai","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0897.1999.tb00468.x","article-title":"Progesterone-induced blocking factor inhibits degranulation of natural killer cells","volume":"42","author":"Faust","year":"1999","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0025","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.fertnstert.2017.04.019","article-title":"Contribution of immunology to implantation failure of euploid embryos","volume":"107","author":"Franasiak","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.clim.2021.108858_bb0030","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1007\/s00018-013-1404-3","article-title":"Progesterone-induced blocking factor differentially regulates trophoblast and tumor invasion by altering matrix metalloproteinase activity","volume":"70","author":"Halasz","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.clim.2021.108858_bb0035","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017560","article-title":"Efficacy and safety of moxibustion in female infertility patients undergoing in vitro fertilization and embryo transfer: a systematic review protocol","volume":"98","author":"Hou","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2021.108858_bb0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1515\/JPM.2009.061","article-title":"Progesterone - induced blocking factor (PIBF) and Th(1)\/Th(2) cytokine in women with threatened spontaneous abortion","volume":"37","author":"Hudic","year":"2009","journal-title":"J. Perinat. Med."},{"key":"10.1016\/j.clim.2021.108858_bb0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1600-0897.2009.00699.x","article-title":"Progesterone-induced blocking factor and cytokine profile in women with threatened pre-term delivery","volume":"61","author":"Hudic","year":"2009","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jri.2015.02.006","article-title":"Maternal serum progesterone-induced blocking factor (PIBF) in the prediction of preterm birth","volume":"109","author":"Hudic","year":"2015","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jri.2011.08.006","article-title":"Dydrogesterone supplementation in women with threatened preterm delivery--the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor","volume":"92","author":"Hudic","year":"2011","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jri.2016.07.003","article-title":"Lower urinary and serum progesterone-induced blocking factor in women with preterm birth","volume":"117","author":"Hudic","year":"2016","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0065","doi-asserted-by":"crossref","first-page":"103150","DOI":"10.1016\/j.jri.2020.103150","article-title":"Progesterone induced blocking factor (PIBF) taken in early pregnancy predicts the pregnancy outcome in women undergoing in vitro fertilization procedure","volume":"140","author":"Hudic","year":"2020","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0070","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1600-0897.2005.00261.x","article-title":"The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion","volume":"53","author":"Kalinka","year":"2005","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0075","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3109\/09513590.2015.1031103","article-title":"How can we better predict the risk of spontaneous miscarriage among women experiencing threatened miscarriage?","volume":"31","author":"Ku","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.clim.2021.108858_bb0080","doi-asserted-by":"crossref","first-page":"e13429","DOI":"10.1111\/aji.13429","article-title":"Increasing number of implantation failures and pregnancy losses associated with elevated Th1\/Th2 cell ratio","volume":"86","author":"Kuroda","year":"2021","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/aji.12320","article-title":"Increased circulating Th1\/Th2 ratios but not other lymphocyte subsets during controlled ovarian stimulation are linked to subsequent implantation failure after transfer of in vitro fertilized embryos","volume":"73","author":"Liang","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0090","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1038\/s41598-020-59452-y","article-title":"Characterisation of serum progesterone and progesterone-induced blocking factor (PIBF) levels across trimesters in healthy pregnant women","volume":"10","author":"Lim","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2021.108858_bb0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/aji.12338","article-title":"Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1\/TH2 cell ratios","volume":"73","author":"Nakagawa","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-4755-11-76","article-title":"Assisted reproductive technologies (ARTs): evaluation of evidence to support public policy development","volume":"11","author":"Nardelli","year":"2014","journal-title":"Reprod. Health"},{"key":"10.1016\/j.clim.2021.108858_bb0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jri.2009.01.004","article-title":"Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery","volume":"80","author":"Raghupathy","year":"2009","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0110","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1172\/JCI122182","article-title":"Regulatory T cells in embryo implantation and the immune response to pregnancy","volume":"128","author":"Robertson","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2021.108858_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejogrb.2020.05.069","article-title":"The role of serum progesterone induced blocking factor on unexplained infertility","volume":"252","author":"Sahin","year":"2020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.clim.2021.108858_bb0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0165-0378(83)90237-1","article-title":"Differential actions of progesterone and cortisol on lymphocyte and monocyte interaction during lymphocyte activation--relevance to immunosuppression in pregnancy","volume":"5","author":"Stites","year":"1983","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000491576","article-title":"The role of progesterone in feto-maternal immunological cross talk","volume":"27","author":"Szekeres-Bartho","year":"2018","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.clim.2021.108858_bb0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jri.2009.06.262","article-title":"Progesterone in pregnancy; receptor-ligand interaction and signaling pathways","volume":"83","author":"Szekeres-Bartho","year":"2009","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0897.1985.tb00334.x","article-title":"The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: I. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis","volume":"9","author":"Szekeres-Bartho","year":"1985","journal-title":"Am. J. Reprod. Immunol. Microb."},{"key":"10.1016\/j.clim.2021.108858_bb0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0897.2010.00833.x","article-title":"PIBF: the double edged sword. Pregnancy and tumor","volume":"64","author":"Szekeres-Bartho","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bpobgyn.2019.07.001","article-title":"Progestogens and immunology","volume":"60","author":"Szekeres-Bartho","year":"2019","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.clim.2021.108858_bb0150","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1600-0897.1997.tb00321.x","article-title":"Cytokine production by lymphocytes in pregnancy","volume":"38","author":"Szereday","year":"1997","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clinbiochem.2018.03.012","article-title":"Fertility and infertility: definition and epidemiology","volume":"62","author":"Vander Borght","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clim.2021.108858_bb0160","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fimmu.2020.02025","article-title":"T helper (Th) cell profiles in pregnancy and recurrent pregnancy losses: Th1\/Th2\/Th9\/Th17\/Th22\/Tfh cells","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2021.108858_bb0165","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0897.2011.01018.x","article-title":"Elevated preconception CD56+ 16+ and\/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF","volume":"66","author":"Winger","year":"2011","journal-title":"Am. J. Reprod. Immunol. (New York, N.Y.: 1989)"},{"key":"10.1016\/j.clim.2021.108858_bb0170","first-page":"960","article-title":"Identification of factors related to fertilization failure in in vitro fertilization-embryo transfer","volume":"45","author":"Xia","year":"2020","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.clim.2021.108858_bb0175","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.21037\/atm-20-397","article-title":"Peroxiredoxin 4, a new oxidative stress marker in follicular fluid, may predict in vitro fertilization and embryo transfer outcomes","volume":"8","author":"Yi","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.clim.2021.108858_bb0180","first-page":"653","article-title":"Recurrent implantation failure: a comprehensive review","volume":"68","author":"Zohni","year":"2016","journal-title":"Minerva Ginecol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:05:02Z","timestamp":1761494702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661621001959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":36,"alternative-id":["S1521661621001959"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2021.108858","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progesterone-induced blocking factor-mediated Th1\/Th2 balance correlates with fetal arrest in women who underwent in vitro fertilization and embryo transfer","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2021.108858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108858"}}